NACL Industries Ltd., a prominent agrochemical manufacturer listed on the National Stock Exchange and BSE, has announced that Friday, December 12, 2025, will serve as the record date for its much-anticipated rights issue. The confirmation follows the recent approvals granted by both stock exchanges—NSE on December 4 and BSE on December 5—allowing the company to proceed with the capital-raising initiative.
The company had first signaled its intention to launch a rights issue during its Board meeting on December 1, 2025. This was later followed by the Securities Rights Issue Committee, which finalized the detailed terms and conditions on December 8, marking a key step toward executing the offering.
Structure and Scale of the Rights Issue
The rights issue will see the allocation of 3,25,01,851 fully paid-up equity shares, each carrying a face value of Re 1. If fully subscribed, the total issue size will amount to ₹249.29 crore. The issue price has been fixed at ₹76.70 per share, comprising a premium of ₹75.70 on the face value. The pricing structure aims to offer existing shareholders an opportunity to increase their holding at an attractive rate while enabling the company to raise funds for its ongoing and future growth strategies.
Eligibility and Entitlement
Under the approved entitlement ratio, shareholders will receive 5 rights shares for every 31 shares they hold as on the record date. Only investors whose names appear on the company’s register at the close of business on December 12 will be eligible. This structure ensures that the issue remains shareholder-centric, offering loyal investors a chance to deepen their stake at a preferential price.
Issue Schedule and Renunciation Window
The rights issue will officially open on Monday, December 22, 2025. Investors who do not wish to subscribe can choose to renounce their rights in favor of others through the on-market renunciation facility. This window will be available from December 22 to December 24, 2025, allowing flexibility for redistribution. The issue will close on Tuesday, December 30, 2025, giving investors ample time to evaluate and act according to their investment strategy.
Background and Earlier Announcements
The upcoming rights issue aligns with the company’s earlier disclosures made on December 1 and December 8, where it outlined plans to issue 3.25 crore shares priced at ₹76.70 each, aggregating to around ₹249.29 crore. The consistent communication reflects the company’s intention to raise capital efficiently while maintaining transparency with investors.
About NACL Industries
NACL Industries, formerly known as Nagarjuna Agrichem, is a well-established agrochemical company under the Murugappa Group. The company produces a wide range of crop protection solutions, including insecticides, fungicides, herbicides, acaricides, plant growth products, and both technical-grade and formulation-based chemicals. With a strong farmer-centric approach, NACL operates an extensive distribution network spanning over 50,000 retail touchpoints across India and exports to more than 30 international markets.
Incorporated in 1986, the company transitioned into the agrochemical sector in 1993 and rebranded itself as NACL Industries in 2017. Its consistent focus on research, innovation, sustainability, and responsible manufacturing practices has helped it maintain a robust position in the domestic and global markets. As of the latest available data, NACL Industries has a market capitalization of ₹3,879 crore.
Summary
NACL Industries has designated December 12, 2025, as the record date for its ₹249.29 crore rights issue. Eligible shareholders will receive five rights shares for every 31 held, priced at ₹76.70 each. The issue opens on December 22 and closes on December 30, with an on-market renunciation window from December 22–24. The offering aligns with the company’s earlier announcements and aims to raise capital while giving existing investors a discounted entry. NACL Industries, part of the Murugappa Group, is a leading agrochemical producer with strong domestic and international presence.
Disclaimer:
This article is intended solely for educational and informational purposes. The securities or companies mentioned are provided as examples and should not be considered as recommendations. Nothing contained herein constitutes personal financial advice or investment recommendations. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions.
Investments in securities markets are subject to market risks. Please read all related documents carefully before investing.